Pharma News, 2022

The adaptive immune system identifies and responds to different pathogens that humans experience throughout their lives. 

Yale scientists have uncovered its role in regulating body weight by studying the correlation of a protein called augmentor-alpha with cancer. 

Israel-based RedHill Biopharma said that its dual-action investigational COVID-19 oral antiviral and anti-inflammatory drug opaganib has shown potential efficacy against the Omicron subvariants BA...

Novartis is undertaking a huge restructuring to simplify its organization, and some of its employees will feel the pain.

Pfizer’s COVID-19 vaccine and antiviral show little sign of slowing down in the pandemic’s third year. Now, the company’s oral therapy is getting a boost across the Atlantic. ...

The FDA has amended its Emergency Use Authorization (EUA) for Johnson & Johnson’s COVID-19 vaccine, extending the vaccine’s shelf life from nine months to 11 months, provided the doses are ...

The second-generation gene therapy for hemophilia A called ASC618 has received Fast Track Designation from the US Food and Drug Administration (FDA), as published in a press release.  ...

OXFORD, England--(BUSINESS WIRE)--Neuro-Bio Ltd, a biotechnology company developing a first-in-class treatment for neurodegenerative disease, finds its new drug candidate effectively treats the si...

A multi-institutional team including Yale School of Medicine (YSM) has demonstrated the ability to use ultrasound to stimulate specific neurometabolic pathways in the body to prevent or reverse the...

Bayer said it plans to spend more than $2 billion over the next three years on strengthening and expanding its drug and biologic manufacturing operations.

Medicare announced Thursday that it will limit its coverage of the pricey new drug Aduhelm to Alzheimer's patients enrolled in clinical trials of the drug.

Novartis said the FDA has given the go-ahead for its gene therapy manufacturing facility in Durham, N.C., to manufacture the spinal muscular atrophy drug Zolgensma (onasemnogene abeparvovec) and ot...